Meta‐analysis: Incidence of cirrhosis and hepatocellular carcinoma in patients with Fontan palliation
Asif Hitawala(National Institutes of Health), Theo Heller(National Institutes of Health), Ari Cedars(Providence Sacred Heart Medical Center), Alicia A. Livinski(National Institutes of Health), Maria Mironova(National Institutes of Health), Anitha S. John(Children's National), Harish Gopalakrishna(National Institute of Diabetes and Digestive and Kidney Diseases), Seiji Ito(Children's National), Tacy Downing(Children's Hospital of Philadelphia), Stacy D. Fisher(Adult Congenital Heart Association), Elizabeth C. Wright(National Institute of Diabetes and Digestive and Kidney Diseases)
Cited by 8
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889
Immune dysregulation in human subjects with heterozygous germline mutations in <i>CTLA4</i>
|Science|2014|844
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|726